At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 154 enrolled
Drug / intervention
IDP-118 Vehicle Lotion +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
In Brief
A Phase 2 clinical trial evaluating IDP-118 Vehicle Lotion, IDP-118 Vehicle Cream, and 2 other interventions for Psoriasis. Completed, enrolled 154 participants across 14 sites.
Detailed Summary
Safety and Efficacy of IDP-118 Lotion to Ultravate® Cream, in the Treatment of Plaque Psoriasis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedMay 2016
Primary CompletionDec 2016
Study CompletionJan 2017
TodayJul 2026
First PostedMay 27, 2016
Enrollment StartApr 1, 2016
Primary CompletionDec 1, 2016
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.1 years ago
Interventions
IDP-118 Vehicle Lotiondrug
Vehicle
IDP-118 Vehicle Creamdrug
Vehicle
IDP-118 Lotiondrug
Lotion
Ultravate Creamdrug
Cream